Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 174

1.

The myoepithelial immunophenotype in 135 benign and malignant salivary gland tumors other than pleomorphic adenoma.

Prasad AR, Savera AT, Gown AM, Zarbo RJ.

Arch Pathol Lab Med. 1999 Sep;123(9):801-6.

PMID:
10458827
2.

[Myoepithelial differentiation markers in salivary gland neoplasia].

Scarpellini F, Marucci G, Foschini MP.

Pathologica. 2001 Dec;93(6):662-7. Italian.

PMID:
11785118
4.

Immunohistochemical expression of vimentin, calponin and HHF-35 in salivary gland tumors.

Cavalcante RB, Lopes FF, Ferreira AS, Freitas Rde A, de Souza LB.

Braz Dent J. 2007;18(3):192-7.

6.
7.

CK7+/CK20- immunoexpression profile is typical of salivary gland neoplasia.

Meer S, Altini M.

Histopathology. 2007 Jul;51(1):26-32.

PMID:
17593078
8.

Correlation of human Bub1 expression with tumor-proliferating activity in salivary gland tumors.

Shigeishi H, Yoneda S, Taki M, Nobumori T, Ohta K, Higashikawa K, Yasui W, Kamata N.

Oncol Rep. 2006 Apr;15(4):933-8.

PMID:
16525682
9.

Keratin 14 immunoreactive cells in pleomorphic adenomas and adenoid cystic carcinomas of salivary glands.

Ogawa Y, Toyosawa S, Ishida T, Ijuhin N.

Virchows Arch. 2000 Jul;437(1):58-68.

PMID:
10963381
10.

p63 expression in salivary gland tumors: role of DeltaNp73L in neoplastic transformation.

Foschini MP, Gaiba A, Cocchi R, Pennesi MG, Pession A.

Int J Surg Pathol. 2005 Oct;13(4):329-35.

PMID:
16273188
11.

Application of immunohistochemistry to the diagnosis of salivary gland tumors.

de Araújo VC, de Sousa SO, Carvalho YR, de Araújo NS.

Appl Immunohistochem Mol Morphol. 2000 Sep;8(3):195-202.

PMID:
10981871
12.
13.

WT1 expression in salivary gland pleomorphic adenomas: a reliable marker of the neoplastic myoepithelium.

Langman G, Andrews CL, Weissferdt A.

Mod Pathol. 2011 Feb;24(2):168-74. doi: 10.1038/modpathol.2010.190. Epub 2010 Nov 5.

14.

MUC1 and MUC2 expression in salivary gland tumors and in non-neoplastic salivary gland tissue.

Mannweiler S, Beham A, Langner C.

APMIS. 2003 Oct;111(10):978-84.

PMID:
14616551
15.

Salivary gland tumors studied by means of the AgNOR technique.

Epivatianos A, Trigonidis G.

Ann Dent. 1994 Winter;53(2):21-5.

PMID:
7847771
16.

Hierarchical cluster analysis of myoepithelial/basal cell markers in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma.

Prasad ML, Barbacioru CC, Rawal YB, Husein O, Wen P.

Mod Pathol. 2008 Feb;21(2):105-14. Epub 2007 Dec 14.

17.
18.

Dendritic interstitial and myofibroblastic cells at the border of salivary gland tumors.

Soma L, LiVolsi VA, Baloch ZW.

Arch Pathol Lab Med. 2001 Feb;125(2):232-6.

PMID:
11175641
19.

Immunohistochemical evaluation of the Ca(2+)-binding S-100 proteins S-100A1, S-100A2, S-100A4, S-100A6 and S-100B in salivary gland tumors.

Huang JW, Ming Z, Shrestha P, Mori M, Ilg E, Schäfer BW, Heizmann CW.

J Oral Pathol Med. 1996 Nov;25(10):547-55.

PMID:
8986967
20.

Myoepithelial cells in salivary gland tumors. An immunohistochemical study.

Kahn HJ, Baumal R, Marks A, Dardick I, van Nostrand AW.

Arch Pathol Lab Med. 1985 Feb;109(2):190-5.

PMID:
2579620

Supplemental Content

Support Center